MedTrace Logo

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

NCT03651453 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2021-07-28

No results posted yet for this study

Summary

To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.

Conditions

Interventions

BEHAVIORAL

Decision aid

Participants in the experimental arm will receive the PrEP decision aid.

BEHAVIORAL

Standard care

Standard harm reduction information

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Jaimie P Meyer, MD · Yale University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2020-06-11
Completion
2020-06-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03651453 on ClinicalTrials.gov